(JEN) Jenoptik - Overview
Sector: Technology | Industry: Electronic Components | Exchange: XETRA (Germany) | Market Cap: 2.545m EUR | Total Return: 141.4% in 12m
Avg Turnover: 8.27M
EPS Trend: 28.5%
Qual. Beats: 1
Rev. Trend: -6.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Supp Ema20, Rs Leader, Idiosyncratic Leader, Garp
Jenoptik AG is a German-based technology group specializing in photonics and smart mobility. The company operates through four primary segments: Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions. Its product portfolio includes high-precision optics, laser systems, digital imaging modules, and optoelectronic assemblies used in diverse industries such as healthcare, automotive, and semiconductor manufacturing.
The companys business model transitions from being a pure component supplier to a systems integrator, focusing on high-growth markets like semiconductor equipment and medical technology. In the photonics sector, companies often maintain deep integration with customer R&D cycles, as customized optical components are critical to the performance of end-user lithography and diagnostic tools.
Beyond industrial applications, Jenoptik provides public safety infrastructure, including automated speed enforcement, red-light monitoring, and number plate recognition software. This segment relies on long-term government contracts and recurring service revenue, providing a defensive hedge against the cyclicality often found in the broader technology and capital goods markets.
Investors can further evaluate these revenue streams and segment performance by reviewing the detailed financial breakdowns on ValueRay.
- Semiconductor manufacturing equipment demand fuels core revenue and order backlog growth
- Expansion in biophotonics and medical technology stabilizes long-term margin profiles
- Global automotive production cycles influence metrology and production solutions division earnings
- Government infrastructure spending on smart mobility and road safety drives recurring revenue
- Exposure to cyclical industrial capital expenditure impacts overall organic growth targets
| Net Income: 79.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 31.63% < 20% (prev 17.34%; Δ 14.29% < -1%) |
| CFO/TA 0.10 > 3% & CFO 163.5m > Net Income 79.5m |
| Net Debt (371.1m) to EBITDA (202.4m): 1.83 < 3 |
| Current Ratio: 2.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.2m) vs 12m ago -1.25% < -2% |
| Gross Margin: 33.19% > 18% (prev 0.33%; Δ 3.29k% > 0.5%) |
| Asset Turnover: 61.56% > 50% (prev 65.50%; Δ -3.94% > 0%) |
| Interest Coverage Ratio: 5.67 > 6 (EBITDA TTM 202.4m / Interest Expense TTM 22.1m) |
| A: 0.19 (Total Current Assets 586.1m - Total Current Liabilities 256.1m) / Total Assets 1.71b |
| B: 0.37 (Retained Earnings 633.6m / Total Assets 1.71b) |
| C: 0.07 (EBIT TTM 125.3m / Avg Total Assets 1.70b) |
| D: 1.23 (Book Value of Equity 830.0m / Total Liabilities 675.3m) |
| Altman-Z'' = 4.27 = AA |
| DSRI: 1.16 (Receivables 221.3m/201.3m, Revenue 1.04b/1.10b) |
| GMI: 1.00 (GM 33.19% / 33.03%) |
| AQI: 0.97 (AQ_t 0.41 / AQ_t-1 0.42) |
| SGI: 0.95 (Revenue 1.04b / 1.10b) |
| TATA: -0.05 (NI 79.5m - CFO 163.5m) / TA 1.71b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of May 26, 2026, the stock is trading at EUR 45.04 with a total of 91,649 shares traded.
Over the past week, the price has changed by +3.78%,
over one month by +38.93%,
over three months by +59.60% and
over the past year by +141.35%.
Jenoptik has no consensus analysts rating.
P/E Trailing = 37.3613
P/E Forward = 16.2602
P/S = 2.4385
P/B = 2.3816
P/EG = 1.1285
Revenue TTM = 1.04b EUR
EBIT TTM = 125.3m EUR
EBITDA TTM = 202.4m EUR
Long Term Debt = 369.7m EUR (estimated: total debt 394.2m - short term 24.5m)
Short Term Debt = 24.5m EUR (from shortTermDebt, last quarter)
Debt = 455.3m EUR (from shortLongTermDebtTotal, last quarter) + Leases 61.1m
Net Debt = 371.1m EUR (calculated: Debt 455.3m - CCE 84.2m)
Enterprise Value = 2.92b EUR (2.54b + Debt 455.3m - CCE 84.2m)
Interest Coverage Ratio = 5.67 (Ebit TTM 125.3m / Interest Expense TTM 22.1m)
EV/FCF = 26.59x (Enterprise Value 2.92b / FCF TTM 109.7m)
FCF Yield = 3.76% (FCF TTM 109.7m / Enterprise Value 2.92b)
FCF Margin = 10.51% (FCF TTM 109.7m / Revenue TTM 1.04b)
Net Margin = 7.62% (Net Income TTM 79.5m / Revenue TTM 1.04b)
Gross Margin = 33.19% ((Revenue TTM 1.04b - Cost of Revenue TTM 697.3m) / Revenue TTM)
Gross Margin QoQ = 35.41% (prev 32.79%)
Tobins Q-Ratio = 1.71 (Enterprise Value 2.92b / Total Assets 1.71b)
Interest Expense / Debt = 4.85% (Interest Expense 22.1m / Debt 455.3m)
Taxrate = 28.81% (6.78m / 23.5m)
NOPAT = 89.2m (EBIT 125.3m * (1 - 28.81%))
Current Ratio = 2.29 (Total Current Assets 586.1m / Total Current Liabilities 256.1m)
Debt / Equity = 0.44 (Debt 455.3m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 1.83 (Net Debt 371.1m / EBITDA 202.4m)
Debt / FCF = 3.38 (Net Debt 371.1m / FCF TTM 109.7m)
Total Stockholder Equity = 990.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.69% (Net Income 79.5m / Total Assets 1.71b)
RoE = 8.03% (Net Income TTM 79.5m / Total Stockholder Equity 990.0m)
RoCE = 9.22% (EBIT 125.3m / Capital Employed (Equity 990.0m + L.T.Debt 369.7m))
RoIC = 6.05% (NOPAT 89.2m / Invested Capital 1.47b)
WACC = 8.48% (E(2.54b)/V(3.00b) * Re(9.38%) + D(455.3m)/V(3.00b) * Rd(4.85%) * (1-Tc(0.29)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 29.55 | Cagr: 0.00%
[DCF] Terminal Value 77.55% ; FCFF base≈97.5m ; Y1≈111.8m ; Y5≈164.5m
[DCF] Fair Price = 35.79 (EV 2.42b - Net Debt 371.1m = Equity 2.05b / Shares 57.2m; r=8.48% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 28.46 | EPS CAGR: 3.38% | SUE: 4.0 | # QB: 1
Revenue Correlation: -6.33 | Revenue CAGR: -0.19% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.39 | Chg30d=+0.00% | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.59 | Chg30d=+0.00% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=1.82 | Chg30d=+5.12% | Revisions=+50% | GrowthEPS=+50.8% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=2.18 | Chg30d=+4.38% | Revisions=+33% | GrowthEPS=+20.3% | GrowthRev=+8.0%
[Analyst] Revisions Ratio: +50%